LUNG INFILTRATION side effect
What is LUNG INFILTRATION ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
LUNG INFILTRATION and Recently Reported Side Effects
LUNG INFILTRATION and 15 most Active Side Effect polls
LUNG INFILTRATION and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with LUNG INFILTRATION
ACTONEL ADVAIR ALTACE AMIODARONE AMOXICILLIN ARANESP ARAVA ARICEPT AVANDIA AVASTIN AVONEX BEVACIZUMAB CABERGOLINE CAPECITABINE CARBOPLATIN CARMUSTINE CEFUROXIME CELLCEPT CETUXIMAB CISPLATIN CLARITHROMYCIN CLOPIDOGREL COTRIM CUBICIN CYCLOPHOSPHAMIDE CYTARABINE DACOGEN DAPTOMYCIN DASATINIB DECITABINE DOXORUBICIN ERLOTINIB ESCITALOPRAM EVEROLIMUS FLUDARABINE FLUOROURACIL FOLINIC GEMTUZUMAB GEMZAR GLEEVEC HEPSERA HERCEPTIN HUMIRA IBUPROFEN IMATINIB INFLIXIMAB INTRON INVANZ IRESSA KALETRA LAMIVUDINE LENALIDOMIDE MABTHERA MACROBID MYCOPHENOLATE MYLOTARG NEULASTA NEXAVAR NORDETTE NOXAFIL ORTHO OXALIPLATIN PACERONE PACLITAXEL PENTASA PLASMARC PREDNISOLONE PROPOFOL PROPYLTHIOURACIL RAPAMUNE RAPTIVA REBIF RED REMICADE REVLIMID RIFAMPICIN RITUXAN RITUXIMAB SEVORANE SINGULAIR SORAFENIB SPRYCEL SUBOXONE SUTENT SYNAGIS TAMOXIFEN TAVOR TAXOTERE TEMODAL TEMODAR TEMOZOLOMIDE THYMOGLOBULIN TORISEL TRACLEER TRETINOIN TYSABRI VECTIBIX VELCADE VERAPAMIL VESANOID ZITHROMAXFludarabine Side Effects Report #5679988-7
Consumer or non-health professional from UNITED STATES reported FLUDARABINE PHOSPHATE problem on Mar 25, 2008. Male patient, weighting 138.9 lb, was diagnosed with non-hodgkin's lymphoma and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary alveolar haemorrhage, . FLUDARABINE PHOSPHATE dosage: 55MG 5 DAYS IV. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
Sprycel Side Effects Report #5682598-9
SPRYCEL problem was reported by a Health Professional from UNITED STATES on Feb 21, 2008. Female patient was diagnosed with langerhans' cell granulomatosis and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . SPRYCEL dosage: ALSO TAKEN 50MG DAILY. Patient recovered.
Cytarabine Side Effects Report #5631764-7
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Feb 19, 2008. Male patient, weighting 280.2 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pneumonitis, . CYTARABINE dosage: 1820 MG. During the same period patient was treated with DAUNORUBICIN. Patient was hospitalized. Patient recovered.
Tysabri Side Effects Report #5586068-8
TYSABRI problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 27, 2007. Male patient, 51 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: lung infiltration, lymphocyte percentage increased, neutropenic sepsis, white blood cell count decreased, . TYSABRI dosage: 300 MG;QM;IV. During the same period patient was treated with NEURONTIN, MIRAPEX, LAMICTAL, PROVIGIL, ZOCOR, FLUVOXAMINE MALEATE, VIAGRA. Patient was hospitalized. Patient recovered.
Raptiva Side Effects Report #5592465-7
Physician from UNITED STATES reported RAPTIVA problem on Jan 15, 2008. Female patient was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . RAPTIVA dosage: unknown. Patient recovered.
Sutent Side Effects Report #5603277-X
SUTENT problem was reported by a Consumer or non-health professional from CANADA on Jan 16, 2008. Male patient, weighting 145.5 lb, was diagnosed with renal cell carcinoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . SUTENT dosage: unknown. During the same period patient was treated with LIPITOR, RAMIPRIL, ZANTAC, LEVOTHYROXINE, HYDROCHLOROTHIAZIDE, LOPERAMIDE. Patient was hospitalized. Patient recovered.
Cabergoline Side Effects Report #5606736-9
Health Professional from SWEDEN reported CABERGOLINE problem on Jan 21, 2008. Male patient, 72 years of age, was diagnosed with parkinson's disease and was treated with CABERGOLINE. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pleural fibrosis, . CABERGOLINE dosage: unknown. During the same period patient was treated with HEMINEVRIN, ALVEDON, OXYCONTIN, CIPRAMIL, DUROFERON, ZAROXOLYN, FURIX, KALCITENA. Patient was hospitalized. Patient recovered.
Sprycel Side Effects Report #5609383-8
SPRYCEL problem was reported by a Health Professional from ISRAEL on Jan 24, 2008. Male patient, 17 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . SPRYCEL dosage: unknown. Patient died.
Escitalopram Side Effects Report #5570102-5
Consumer or non-health professional from SPAIN reported ESCITALOPRAM problem on Nov 30, 2007. Male patient, 60 years of age, was diagnosed with depression and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pyrexia, rash, . ESCITALOPRAM dosage: 10 MG QD PO. During the same period patient was treated with IDALPREM, DILTIAZEM, EDEMOX, HALOPERIDOL, VITAMIN B, FOLIC ACID. Patient recovered.
Nexavar Side Effects Report #5576703-2
NEXAVAR problem was reported by a Physician from UNITED STATES on Dec 20, 2007. Male patient, 84 years of age, was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient recovered.
Amiodarone Side Effects Report #5599501-2
Physician from UNITED STATES reported AMIODARONE HYDROCHLORIDE problem on Jan 17, 2007. Male patient, 65 years of age, weighting 222.0 lb, was diagnosed with cardiomegaly, ventricular arrhythmia and was treated with AMIODARONE HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary toxicity, respiratory failure, . AMIODARONE HYDROCHLORIDE dosage: 200 MG (200 MG, 1 IN 1 D). During the same period patient was treated with AMIODARONE HYDROCHLORIDE, SALBUTAMOL, QUINAPRIL, ACETYLSALICYLIC ACID SRT, WARFARIN, DIGOXIN, FLUTICASONE PROPIONATE, FUROSEMIDE. Patient was hospitalized. Patient died on 12/21/2006.
Raptiva Side Effects Report #5519355-X
RAPTIVA problem was reported by a Physician from UNITED STATES on Nov 12, 2007. Female patient was treated with RAPTIVA. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . RAPTIVA dosage: unknown. Patient recovered.
Remicade Side Effects Report #5522943-8
Physician from SWEDEN reported REMICADE problem on Nov 12, 2007. Female patient, 48 years of age, was diagnosed with crohn's disease and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pyrexia, vasculitis, . REMICADE dosage: unknown. Patient recovered.
Rituxan Side Effects Report #5477377-1
RITUXAN problem was reported by a Physician from GERMANY on Sept 26, 2007. Male patient, 45 years of age, was treated with RITUXAN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . RITUXAN dosage: 375 MG/M2, Q4W. During the same period patient was treated with LEFLUNOMIDE, PREDNISOLONE. Patient recovered.
Tretinoin Side Effects Report #5485315-0
Pharmacist from UNITED STATES reported TRETINOIN problem on Oct 10, 2007. Male patient, 31 years of age, weighting 273.2 lb, was diagnosed with acute promyelocytic leukaemia and was treated with TRETINOIN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pleural effusion, pyrexia, respiratory distress, weight increased, . TRETINOIN dosage: 60 MG Q 12 HR PO. Patient recovered.
Daptomycin Side Effects Report #5493170-8
DAPTOMYCIN problem was reported by a Physician from UNITED STATES on Oct 22, 2007. Female patient, weighting 123.5 lb, was diagnosed with bacteraemia and was treated with DAPTOMYCIN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, oxygen saturation decreased, . DAPTOMYCIN dosage: 330 MG Q 24 HRS IV. During the same period patient was treated with RIFAMPIN, PYRIDIUM, PROTONIX, COUMADIN, MEGACE, NORCO, DILTIAZEM, ADVAIR DISKUS. Patient was hospitalized and became disabled. Patient recovered.
Cubicin Side Effects Report #5494100-5
Physician from UNITED STATES reported CUBICIN problem on Oct 09, 2007. Female patient, 86 years of age, weighting 123.5 lb, was diagnosed with bacteraemia, staphylococcal infection and was treated with CUBICIN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . CUBICIN dosage: 5.9 MG/ KG; Q24H; IV. During the same period patient was treated with PYRIDIUM, PREDNISONE, COUMADIN, FLUTICASONE PROPIONATE W, REGLAN, RIFAMPIN, DILTIAZEM. Patient was hospitalized. Patient recovered.
Arava Side Effects Report #5503154-9
ARAVA problem was reported by a Physician from SOUTH AFRICA on Oct 24, 2007. Female patient, 71 years of age, was diagnosed with rheumatoid arthritis, hypertension, gastritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary granuloma, pulmonary hypertension, . ARAVA dosage: unknown. During the same period patient was treated with DAPAMAX, OMEPRAZOLE, PREXUM, IMDUR, ECOTRIN, CILIFT. Patient was hospitalized and became disabled. Patient recovered.
Imatinib Side Effects Report #5441343-2
Consumer or non-health professional from UNITED STATES reported IMATINIB MESYLATE problem on Aug 27, 2007. Female patient, 49 years of age, weighting 163.1 lb, was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB MESYLATE. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . IMATINIB MESYLATE dosage: 400 MG, QD. During the same period patient was treated with IMATINIB MESYLATE, PREDNISONE, PANTOPRAZOLE, DILTIAZEM, LEVOTHYROXINE, AZATHIOPRINE, ZOLPIDEM TARTRATE. Patient recovered.
Arava Side Effects Report #5447297-7
ARAVA problem was reported by a Physician from SOUTH AFRICA on Aug 29, 2007. Female patient, 71 years of age, was diagnosed with rheumatoid arthritis, hypertension, gastritis and was treated with ARAVA. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary granuloma, pulmonary hypertension, . ARAVA dosage: unknown. During the same period patient was treated with DAPAMAX, OMEPRAZOLE, PREXUM, IMDUR, ECOTRIN, CILIFT. Patient was hospitalized and became disabled. Patient recovered.
Dacogen Side Effects Report #5470085-2
Consumer or non-health professional from UNITED STATES reported DACOGEN problem on Sept 12, 2007. Female patient was treated with DACOGEN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary haemorrhage, . DACOGEN dosage: unknown. Patient recovered.
Sutent Side Effects Report #5406637-5
SUTENT problem was reported by a Pharmacist from CANADA on July 26, 2007. Male patient, 42 years of age, was diagnosed with malignant melanoma and was treated with SUTENT. After drug was administered, patient experienced the following problems/side effects: lung infiltration, neutrophil count decreased, po2 decreased, pyrexia, . SUTENT dosage: unknown. During the same period patient was treated with DEXAMETHASONE, RABEPRAZOLE, DILAUDID, PROPRANOLOL. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5429633-0
Physician from UNITED KINGDOM reported BEVACIZUMAB problem on Aug 14, 2007. Male patient, weighting 195.6 lb, was diagnosed with colorectal cancer metastatic and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . BEVACIZUMAB dosage: 667 MG, Q3W. During the same period patient was treated with CAPECITABINE, OXALIPLATIN, FLUOXETINE, SEROQUEL, MORPHINE SULPHATE, COMPAZINE, ANZEMET, OXYCODONE. Patient was hospitalized. Patient died on 08/01/2007.
Gemtuzumab Side Effects Report #5379193-8
GEMTUZUMAB OZOGAMICIN problem was reported by a Physician from GERMANY on June 25, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary haemorrhage, sepsis, . GEMTUZUMAB OZOGAMICIN dosage: 12 MG. During the same period patient was treated with DECORTIN. Patient died on 04/22/2007.
Erlotinib Side Effects Report #5385085-0
Health Professional from UNITED STATES reported ERLOTINIB problem on July 10, 2007. Male patient, 66 years of age, weighting 166.0 lb, was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: lung infiltration, oxygen saturation decreased, pneumonia, procedural complication, pulmonary embolism, . ERLOTINIB dosage: 100MGM EVERY DAY ORAL. Patient died on 06/27/2007.
Ortho Side Effects Report #5414147-4
ORTHO EVRA problem was reported by a Consumer or non-health professional from UNITED STATES on May 16, 2007. Female patient, 40 years of age, weighting 190.0 lb, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary embolism, . ORTHO EVRA dosage: unknown. During the same period patient was treated with TIZANDINE, BUSPIRONE, HYDROCHLOROQUINE, PROTONIX, CLARITIN, ZOLOFT, PHENERGAN, NABUMETONE. Patient was hospitalized. Patient recovered.
Gemtuzumab Side Effects Report #5379193-8
Physician from GERMANY reported GEMTUZUMAB OZOGAMICIN problem on June 25, 2007. Male patient was diagnosed with acute myeloid leukaemia and was treated with GEMTUZUMAB OZOGAMICIN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary haemorrhage, sepsis, . GEMTUZUMAB OZOGAMICIN dosage: 12 MG. During the same period patient was treated with DECORTIN. Patient died on 04/22/2007.
Erlotinib Side Effects Report #5385085-0
ERLOTINIB problem was reported by a Health Professional from UNITED STATES on July 10, 2007. Male patient, 66 years of age, weighting 166.0 lb, was diagnosed with pancreatic carcinoma and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: lung infiltration, oxygen saturation decreased, pneumonia, procedural complication, pulmonary embolism, . ERLOTINIB dosage: 100MGM EVERY DAY ORAL. Patient died on 06/27/2007.
Ortho Side Effects Report #5414147-4
Consumer or non-health professional from UNITED STATES reported ORTHO EVRA problem on May 16, 2007. Female patient, 40 years of age, weighting 190.0 lb, was diagnosed with contraception and was treated with ORTHO EVRA. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pulmonary embolism, . ORTHO EVRA dosage: unknown. During the same period patient was treated with TIZANDINE, BUSPIRONE, HYDROCHLOROQUINE, PROTONIX, CLARITIN, ZOLOFT, PHENERGAN, NABUMETONE. Patient was hospitalized. Patient recovered.
Plasmarc Side Effects Report #5754832-8
PLASMARC problem was reported by a Physician from JAPAN on May 08, 2008. Male patient, 72 years of age, was diagnosed with operative haemorrhage and was treated with PLASMARC. After drug was administered, patient experienced the following problems/side effects: lung infiltration, oxygen saturation decreased, transfusion-related acute lung injury, . PLASMARC dosage: 750 ML; IV. During the same period patient was treated with FRESH FROZEN PLASMA, RED BLOOD CELLS, WHOLE BLOOD, MANNITOL. Patient recovered.
Herceptin Side Effects Report #5761388-2
Physician from UNITED STATES reported HERCEPTIN problem on Feb 26, 2008. Female patient, 66 years of age, was diagnosed with breast cancer and was treated with HERCEPTIN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . HERCEPTIN dosage: unknown. Patient was hospitalized. Patient recovered.
Torisel Side Effects Report #5692403-2
TORISEL problem was reported by a Physician from UNITED STATES on Jan 21, 2008. Female patient was diagnosed with renal cell carcinoma and was treated with TORISEL. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . TORISEL dosage: unknown. Patient was hospitalized. Patient recovered.
Folinic Side Effects Report #5346207-0
Physician from SWITZERLAND reported FOLINIC ACID problem on May 25, 2007. Female patient, 68 years of age, was treated with FOLINIC ACID. After drug was administered, patient experienced the following problems/side effects: lung infiltration, respiratory failure, . FOLINIC ACID dosage: unknown. During the same period patient was treated with FLUOROURACIL, ELOXATIN. Patient died.
Velcade Side Effects Report #5353542-9
VELCADE problem was reported by a Physician from GERMANY on May 25, 2007. Female patient, 42 years of age, was diagnosed with multiple myeloma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pleural disorder, . VELCADE dosage: unknown. During the same period patient was treated with ADRIAMYCIN PFS, DEXAMETHASONE, MELPHALAN, ACYCLOVIR, PANTOZOL, VORICONAZOLE. Patient was hospitalized. Patient recovered.
Temodar Side Effects Report #5364382-9
Physician from UNITED STATES reported TEMODAR problem on June 14, 2007. Female patient, 59 years of age, weighting 174.6 lb, was diagnosed with glioblastoma multiforme and was treated with TEMODAR. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pneumonitis, . TEMODAR dosage: 190 MG; QD; PO. Patient was hospitalized. Patient recovered.
Bevacizumab Side Effects Report #5370522-8
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on June 20, 2007. Male patient, weighting 184.5 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, PEMETREXED, METOPROLOL SUCCINATE, LIPITOR, NEURONTIN, NORVASC, NEXIUM, DARVOCET. Patient was hospitalized. Patient recovered.
Sprycel Side Effects Report #5372415-9
Consumer or non-health professional from UNITED STATES reported SPRYCEL problem on May 08, 2007. Female patient, 59 years of age, weighting 123.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pyrexia, . SPRYCEL dosage: unknown. During the same period patient was treated with COTRIM, OMEPRAZOLE, ACYCLOVIR, DIGOXIN, LEVOFLOXACIN, VANCOMYCIN, METOPROLOL SUCCINATE, ENOXAPARIN. Patient was hospitalized. Patient recovered.
Singulair Side Effects Report #5373429-5
SINGULAIR problem was reported by a Physician from UNITED STATES on June 26, 2007. Female patient, weighting 158.0 lb, was diagnosed with prophylaxis, sinusitis fungal and was treated with SINGULAIR. After drug was administered, patient experienced the following problems/side effects: lung infiltration, rash, . SINGULAIR dosage: unknown. During the same period patient was treated with PULMICORT RESPULES, AMBIEN, ASTELIN, NASONEX. Patient recovered.
Avandia Side Effects Report #5343686-X
Physician from UNITED STATES reported AVANDIA problem on May 31, 2007. Male patient, 47 years of age, weighting 330.7 lb, was diagnosed with diabetes mellitus and was treated with AVANDIA. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pericardial effusion, pleural effusion, . AVANDIA dosage: 2 MG TWICE DAILY ORAL. During the same period patient was treated with TOPROL, ASPIRIN, ALBUTEROL, VITAMIN CAP, HERBALS. Patient was hospitalized. Patient recovered.
Zithromax Side Effects Report #5293836-9
ZITHROMAX problem was reported by a Physician from UNITED STATES on Mar 31, 2007. Female patient, child 9 years of age, was diagnosed with bronchopneumonia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: lung infiltration, urticaria, . ZITHROMAX dosage: unknown. During the same period patient was treated with COUGH AND COLD PREPARATIONS. Patient recovered.
Zithromax Side Effects Report #5295339-4
Physician from UNITED STATES reported ZITHROMAX problem on Mar 31, 2007. Female patient, child 7 years of age, was diagnosed with bronchopneumonia and was treated with ZITHROMAX. After drug was administered, patient experienced the following problems/side effects: lung infiltration, urticaria, . ZITHROMAX dosage: unknown. During the same period patient was treated with ADVAIR DISKUS. Patient recovered.
Bevacizumab Side Effects Report #5300753-4
BEVACIZUMAB problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 16, 2007. Male patient, weighting 184.5 lb, was diagnosed with non-small cell lung cancer and was treated with BEVACIZUMAB. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . BEVACIZUMAB dosage: 15 MG/KG, Q3W. During the same period patient was treated with CARBOPLATIN, PEMETREXED, METOPROLOL SUCCINATE, LIPITOR, NEURONTIN, NORVASC, NEXIUM, DARVOCET. Patient was hospitalized. Patient recovered.
Cetuximab Side Effects Report #5252434-3
Health Professional from GERMANY reported CETUXIMAB problem on Nov 07, 2006. Female patient, 66 years of age, weighting 158.7 lb, was treated with CETUXIMAB. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . CETUXIMAB dosage: unknown. Patient was hospitalized. Patient died.
Capecitabine Side Effects Report #5257176-6
CAPECITABINE problem was reported by a Health Professional from UNITED KINGDOM on Mar 01, 2007. Female patient, 67 years of age, was treated with CAPECITABINE. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . CAPECITABINE dosage: unknown. During the same period patient was treated with LAPATINIB. Patient was hospitalized. Patient recovered.
Iressa Side Effects Report #5263520-6
Pharmacist from UNITED STATES reported IRESSA problem on Jan 23, 2004. Male patient, 70 years of age, was diagnosed with non-small cell lung cancer and was treated with IRESSA. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . IRESSA dosage: 250 MG QD PO. During the same period patient was treated with ZOMETA, PROCRIT, COUMADIN, ATENOLOL, ZOLOFT, ATIVAN. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5263984-8
MYLOTARG problem was reported by a Physician from UNITED STATES on Mar 01, 2007. Female patient, 40 years of age, weighting 141.3 lb, was diagnosed with acute myeloid leukaemia and was treated with MYLOTARG. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pneumonitis, . MYLOTARG dosage: unknown. During the same period patient was treated with DAUNOMYCIN. Patient was hospitalized. Patient recovered.
Nexavar Side Effects Report #5278371-6
Physician from UNITED STATES reported NEXAVAR problem on Mar 20, 2007. Male patient, 84 years of age, was treated with NEXAVAR. After drug was administered, patient experienced the following problems/side effects: lung infiltration, . NEXAVAR dosage: TOTAL DAILY DOSE: 800 MG UNIT DOSE: 200 MG. Patient recovered.
Sprycel Side Effects Report #5279178-6
SPRYCEL problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 22, 2007. Female patient, 59 years of age, weighting 123.5 lb, was diagnosed with acute lymphocytic leukaemia and was treated with SPRYCEL. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pyrexia, . SPRYCEL dosage: unknown. Patient was hospitalized. Patient recovered.
Doxorubicin Side Effects Report #5286330-2
Consumer or non-health professional from NORWAY reported DOXORUBICIN problem on Mar 12, 2007. Female patient, 61 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with DOXORUBICIN. After drug was administered, patient experienced the following problems/side effects: lung infiltration, pneumocystis jiroveci pneumonia, . DOXORUBICIN dosage: ?? (50 MG/M2) INTRAVENOUS (NOT OTHERWISE SPECIFIED). During the same period patient was treated with ETOPOSIDE, RITUXIMAB, PREDNISOLONE, CYCLOPHOSPHAMIDE, VINCRISTINE. Patient recovered.
Mabthera Side Effects Report #5647500-4
MABTHERA problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 20, 2008. Female patient, 32 years of age, was diagnosed with systemic lupus erythematosus and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: haemoptysis, lung infiltration, pyrexia, . MABTHERA dosage: unknown. During the same period patient was treated with CETIRIZINE, OXIKLORIN, PARA, PREDNISOLONE, SANDIMMUNE, TREXAN. Patient was hospitalized. Patient recovered.
Remicade Side Effects Report #5652596-X
Health Professional from SWEDEN reported REMICADE problem on Feb 27, 2008. Female patient, 53 years of age, was diagnosed with colitis ulcerative, psoriatic arthropathy and was treated with REMICADE. After drug was administered, patient experienced the following problems/side effects: alveolitis, lung infiltration, . REMICADE dosage: unknown. During the same period patient was treated with ASACOL, METHOTREXATE, OMEPRAZOLE, FOLACIN. Patient was hospitalized. Patient recovered.